TUTCRIS - Tampereen teknillinen yliopisto

TUTCRIS

General principles for the validation of proarrhythmia risk prediction models: an extension of the CiPA In Silico strategy

Tutkimustuotosvertaisarvioitu

Standard

General principles for the validation of proarrhythmia risk prediction models: an extension of the CiPA In Silico strategy. / Li, Zhihua; Mirams, Gary; Yoshinaga, Takashi; Ridder, Bradley; Han, Xiaomei; Chen, Janell E.; Stockbridge, Norman L.; Wisialowski, Todd A.; Damiano, Bruce; Severi, Stefano; Morissette, Pierre; Kowey, Peter R.; Holbrook, Mark; Smith, Godfrey; Rasmusson, Randall L.; Liu, Michael; Song, Zhen; Qu, Zhilin; Leishman, Derek J.; Steidl‐Nichols, Jill; Rodriguez, Blanca; Bueno-Orovio, Alfonso; Zhou, Xin; Passini, Elisa; Edwards, Andrew G.; Morotti, Stefano; Ni, Haibo; Grandi, Eleonora; Clancy, Colleen E.; Vandenberg, Jamie; Hill, Adam; Nakamura, Mikiko; Singer, Thomas; Polonchuk, Liudmila; Greiter‐Wilke, Andrea; Wang, Ken; Nave, Stephane; Fullerton, Aaron; Sobie, Eric A.; Paci, Michelangelo; Tshinanu, Flora Musuamba; Strauss, David G.

julkaisussa: CLINICAL PHARMACOLOGY AND THERAPEUTICS, 10.11.2019.

Tutkimustuotosvertaisarvioitu

Harvard

Li, Z, Mirams, G, Yoshinaga, T, Ridder, B, Han, X, Chen, JE, Stockbridge, NL, Wisialowski, TA, Damiano, B, Severi, S, Morissette, P, Kowey, PR, Holbrook, M, Smith, G, Rasmusson, RL, Liu, M, Song, Z, Qu, Z, Leishman, DJ, Steidl‐Nichols, J, Rodriguez, B, Bueno-Orovio, A, Zhou, X, Passini, E, Edwards, AG, Morotti, S, Ni, H, Grandi, E, Clancy, CE, Vandenberg, J, Hill, A, Nakamura, M, Singer, T, Polonchuk, L, Greiter‐Wilke, A, Wang, K, Nave, S, Fullerton, A, Sobie, EA, Paci, M, Tshinanu, FM & Strauss, DG 2019, 'General principles for the validation of proarrhythmia risk prediction models: an extension of the CiPA In Silico strategy', CLINICAL PHARMACOLOGY AND THERAPEUTICS. https://doi.org/10.1002/cpt.1647

APA

Li, Z., Mirams, G., Yoshinaga, T., Ridder, B., Han, X., Chen, J. E., ... Strauss, D. G. (2019). General principles for the validation of proarrhythmia risk prediction models: an extension of the CiPA In Silico strategy. CLINICAL PHARMACOLOGY AND THERAPEUTICS. https://doi.org/10.1002/cpt.1647

Vancouver

Li Z, Mirams G, Yoshinaga T, Ridder B, Han X, Chen JE et al. General principles for the validation of proarrhythmia risk prediction models: an extension of the CiPA In Silico strategy. CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2019 marras 10. https://doi.org/10.1002/cpt.1647

Author

Li, Zhihua ; Mirams, Gary ; Yoshinaga, Takashi ; Ridder, Bradley ; Han, Xiaomei ; Chen, Janell E. ; Stockbridge, Norman L. ; Wisialowski, Todd A. ; Damiano, Bruce ; Severi, Stefano ; Morissette, Pierre ; Kowey, Peter R. ; Holbrook, Mark ; Smith, Godfrey ; Rasmusson, Randall L. ; Liu, Michael ; Song, Zhen ; Qu, Zhilin ; Leishman, Derek J. ; Steidl‐Nichols, Jill ; Rodriguez, Blanca ; Bueno-Orovio, Alfonso ; Zhou, Xin ; Passini, Elisa ; Edwards, Andrew G. ; Morotti, Stefano ; Ni, Haibo ; Grandi, Eleonora ; Clancy, Colleen E. ; Vandenberg, Jamie ; Hill, Adam ; Nakamura, Mikiko ; Singer, Thomas ; Polonchuk, Liudmila ; Greiter‐Wilke, Andrea ; Wang, Ken ; Nave, Stephane ; Fullerton, Aaron ; Sobie, Eric A. ; Paci, Michelangelo ; Tshinanu, Flora Musuamba ; Strauss, David G. / General principles for the validation of proarrhythmia risk prediction models: an extension of the CiPA In Silico strategy. Julkaisussa: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2019.

Bibtex - Lataa

@article{32dbdf9be1d34d31909dcd90016ba278,
title = "General principles for the validation of proarrhythmia risk prediction models: an extension of the CiPA In Silico strategy",
author = "Zhihua Li and Gary Mirams and Takashi Yoshinaga and Bradley Ridder and Xiaomei Han and Chen, {Janell E.} and Stockbridge, {Norman L.} and Wisialowski, {Todd A.} and Bruce Damiano and Stefano Severi and Pierre Morissette and Kowey, {Peter R.} and Mark Holbrook and Godfrey Smith and Rasmusson, {Randall L.} and Michael Liu and Zhen Song and Zhilin Qu and Leishman, {Derek J.} and Jill Steidl‐Nichols and Blanca Rodriguez and Alfonso Bueno-Orovio and Xin Zhou and Elisa Passini and Edwards, {Andrew G.} and Stefano Morotti and Haibo Ni and Eleonora Grandi and Clancy, {Colleen E.} and Jamie Vandenberg and Adam Hill and Mikiko Nakamura and Thomas Singer and Liudmila Polonchuk and Andrea Greiter‐Wilke and Ken Wang and Stephane Nave and Aaron Fullerton and Sobie, {Eric A.} and Michelangelo Paci and Tshinanu, {Flora Musuamba} and Strauss, {David G.}",
note = "DUPL=50914053 Merkitty Julk0000 Virta-siirtoa varten",
year = "2019",
month = "11",
day = "10",
doi = "10.1002/cpt.1647",
language = "English",
journal = "CLINICAL PHARMACOLOGY AND THERAPEUTICS",
issn = "0009-9236",
publisher = "American Society for Clinical Pharmacology and Therapeutics",

}

RIS (suitable for import to EndNote) - Lataa

TY - JOUR

T1 - General principles for the validation of proarrhythmia risk prediction models: an extension of the CiPA In Silico strategy

AU - Li, Zhihua

AU - Mirams, Gary

AU - Yoshinaga, Takashi

AU - Ridder, Bradley

AU - Han, Xiaomei

AU - Chen, Janell E.

AU - Stockbridge, Norman L.

AU - Wisialowski, Todd A.

AU - Damiano, Bruce

AU - Severi, Stefano

AU - Morissette, Pierre

AU - Kowey, Peter R.

AU - Holbrook, Mark

AU - Smith, Godfrey

AU - Rasmusson, Randall L.

AU - Liu, Michael

AU - Song, Zhen

AU - Qu, Zhilin

AU - Leishman, Derek J.

AU - Steidl‐Nichols, Jill

AU - Rodriguez, Blanca

AU - Bueno-Orovio, Alfonso

AU - Zhou, Xin

AU - Passini, Elisa

AU - Edwards, Andrew G.

AU - Morotti, Stefano

AU - Ni, Haibo

AU - Grandi, Eleonora

AU - Clancy, Colleen E.

AU - Vandenberg, Jamie

AU - Hill, Adam

AU - Nakamura, Mikiko

AU - Singer, Thomas

AU - Polonchuk, Liudmila

AU - Greiter‐Wilke, Andrea

AU - Wang, Ken

AU - Nave, Stephane

AU - Fullerton, Aaron

AU - Sobie, Eric A.

AU - Paci, Michelangelo

AU - Tshinanu, Flora Musuamba

AU - Strauss, David G.

N1 - DUPL=50914053 Merkitty Julk0000 Virta-siirtoa varten

PY - 2019/11/10

Y1 - 2019/11/10

U2 - 10.1002/cpt.1647

DO - 10.1002/cpt.1647

M3 - Article

JO - CLINICAL PHARMACOLOGY AND THERAPEUTICS

JF - CLINICAL PHARMACOLOGY AND THERAPEUTICS

SN - 0009-9236

ER -